Phase II trial of intratumoral BCNU injection and radiotherapy on untreated adult malignant glioma

By Jenkinson Michael   Smith Trevor   Haylock Brian   Husband David   Shenoy Aditya   Vinjamuri Sobhan   Walker Carol   Pietronigro Denis   Warnke Peter  

Journal of Neuro-Oncology, Vol. 99, Iss. 1, 2010-08 ,pp. : 103-113

Springer Publishing Company

Access to resources Recommend Favorite

Transdermal Delivery of 5-Fluorouracil for Induced Ehrlich Ascites Carcinoma Tumor in Balb/c Mice and Pharmacokinetic Study

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 2, Iss. 3, 2007-11 ,pp. : 235-239

Bentham Science Publishers

Access to resources Recommend Favorite

Increased myelotoxicity of idarubicin: is there a pharmacological basis?: Results of a pharmacokinetic and an in vitro cytotoxicity study

By Kroschinsky Frank   Schleyer Eberhard   Renner Ulf   Schimming Claudia   Schimmelpfennig Christoph   Bornhäuser Martin   Illmer Thomas   Trümper Lorenz   Ehninger Gerhard   Schaich Markus  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 1, 2004-01 ,pp. : 61-67

Springer Publishing Company

Access to resources Recommend Favorite

Intratumoral delivery of mitoxantrone in association with 90-Y radioimmunotherapy (RIT) in recurrent glioblastoma

By Boiardi Amerigo   Bartolomei Mirco   Silvani Antonio   Eoli Marica   Salmaggi Andrea   Lamperti Elena   Milanesi Ida   Botturi Andrea   Rocca Paola   Bodei Lisa   Broggi Giovanni   Paganelli Giovanni  

Journal of Neuro-Oncology, Vol. 72, Iss. 2, 2005-04 ,pp. : 125-131

Springer Publishing Company

Access to resources Recommend Favorite

In situ recruitment of antigen-presenting cells by intratumoral GM-CSF gene delivery

By Pan Ping-Ying   Li Yu   Li Qingsheng   Gu Pedi   Martinet Olivier   Thung Swan   Chen Shu-Hsia  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 1, 2004-01 ,pp. : 17-25

Springer Publishing Company

Access to resources Recommend Favorite